脱落
发表于 2025-3-25 07:14:09
Book 2010om the perspective of comorbidities most common to transplanted patients, including cardiovascular disease, diabetes mellitus, infectious diseases, malignancies, and bone disease. Special issues that impact the care of the transplant recipient, such as unusual donor sources, nonadherence and insurability are also addressed..
同位素
发表于 2025-3-25 09:48:20
http://reply.papertrans.cn/55/5427/542690/542690_22.png
Coma704
发表于 2025-3-25 14:49:13
Kidney Transplantation: A Guide to the Care of Kidney Transplant Recipients978-1-4419-1690-7
abolish
发表于 2025-3-25 17:11:50
978-1-4419-1689-1Springer-Verlag US 2010
adipose-tissue
发表于 2025-3-25 22:45:26
https://doi.org/10.1007/978-1-4419-1690-7Donor; Histocompatibility; Immunosuppression; UNOS; infectious diseases
gene-therapy
发表于 2025-3-26 02:03:16
http://reply.papertrans.cn/55/5427/542690/542690_26.png
MEN
发表于 2025-3-26 06:37:35
What Are Immunosuppressive Medications? How Do They Work? What Are Their Side Effects?,Effective suppression of the transplant recipient’s immune system has improved short-term outcomes in renal transplantation. The immunologic basis for graft rejection is described in Chapter 3. Although there are infrequent reports of patients requiring little or no immunosuppressive medications, most patients require life-long immunosuppression.
季雨
发表于 2025-3-26 11:32:41
The Kidney Transplant Biopsy,The kidney transplant biopsy is an important tool for the diagnosis of kidney transplant dysfunction, and with advances in clinical kidney transplantation, biopsies are increasingly being used to help guide therapy and therapy choice.
与野兽博斗者
发表于 2025-3-26 13:56:53
Infections in Kidney Transplant Recipients,Infections are common in recipients of kidney transplants due primarily to immunosuppressive medications prescribed to prevent rejection of the allograft. This chapter describes current strategies for preventing, recognizing, and treating infectious diseases in kidney transplant recipients.
VALID
发表于 2025-3-26 20:13:02
Kidney Allocation: Role of UNOS and OPOs, charity under IRC section 501(c)(3). Since 1986, it has been the sole holder of a contract from the federal government to operate the national OPTN. Its story is one of the many remarkable successes in organ transplantation.